Latest News in the pharma Industry

Biopharma News

GSK Strengthens Early-Stage Vaccine Pipeline with Acquisition of GlycoVaxyn AG

GSK Strengthens Early-Stage Vaccine Pipeline with Acquisition of GlycoVaxyn AG

12 Feb 2015

Read more 
Vaxxas Raises A$25 Million in Series B Venture Financing to Accelerate Commercialization of Novel Vaccine Platform

Vaxxas Raises A$25 Million in Series B Venture Financing to Accelerate Commercialization of Novel Vaccine Platform

10 Feb 2015

Read more 
Synta Outlines New Corporate Strategy, Including Another Staff Cut

Synta Outlines New Corporate Strategy, Including Another Staff Cut

6 Feb 2015

Read more 
Thermo Fisher Scientific Strengthens Bioproduction Offering by Acquiring Advanced Scientifics, Inc.

Thermo Fisher Scientific Strengthens Bioproduction Offering by Acquiring Advanced Scientifics, Inc.

5 Feb 2015

Read more 
Amgen Announces Positive Top-Line Results from Phase III Study Evaluating the Efficacy and Safety of Biosimilar Candidate ABP 501

Amgen Announces Positive Top-Line Results from Phase III Study Evaluating the Efficacy and Safety of Biosimilar Candidate ABP 501

4 Feb 2015

Read more 
EMA Accepts Samsung Bioepis’ Enbrel Biosimilar Candidate, SB4, for Regulatory Review

EMA Accepts Samsung Bioepis’ Enbrel Biosimilar Candidate, SB4, for Regulatory Review

29 Jan 2015

Read more 
BIO Praises the Release of the 21st Century Cures Initiative Discussion Draft

BIO Praises the Release of the 21st Century Cures Initiative Discussion Draft

28 Jan 2015

Read more 
Catalent Biologics and MGC Pharma Announce Partnership for Biomanufacturing in Asia

Catalent Biologics and MGC Pharma Announce Partnership for Biomanufacturing in Asia

20 Jan 2015

Read more 
Specificity-Verified Monoclonal Antibodies

Specificity-Verified Monoclonal Antibodies

16 Jan 2015

Read more 
Shire to Acquire NPS Pharma as Further Step in Building a Leading Biotech

Shire to Acquire NPS Pharma as Further Step in Building a Leading Biotech

14 Jan 2015

Read more 
Hospira Submits New Biologics License Application to FDA for Proposed Epoetin Alfa Biosimilar

Hospira Submits New Biologics License Application to FDA for Proposed Epoetin Alfa Biosimilar

13 Jan 2015

Read more 
Sandoz Biosimilar Filgrastim Recommended for Approval by FDA Oncologic Drugs Advisory Committee

Sandoz Biosimilar Filgrastim Recommended for Approval by FDA Oncologic Drugs Advisory Committee

9 Jan 2015

Read more